Title : Characterization of a Robust and pH-Stable Tannase from Mangrove-Derived Yeast Rhodosporidium diobovatum Q95 - Pan_2020_Mar.Drugs_18_ |
Author(s) : Pan J , Wang NN , Yin XJ , Liang XL , Wang ZP |
Ref : Mar Drugs , 18 : , 2020 |
Abstract :
Tannase plays a crucial role in many fields, such as the pharmaceutical industry, beverage processing, and brewing. Although many tannases derived from bacteria and fungi have been thoroughly studied, those with good pH stabilities are still less reported. In this work, a mangrove-derived yeast strain Rhodosporidium diobovatum Q95, capable of efficiently degrading tannin, was screened to induce tannase, which exhibited an activity of up to 26.4 U/mL after 48 h cultivation in the presence of 15 g/L tannic acid. The tannase coding gene TANRD was cloned and expressed in Yarrowia lipolytica. The activity of recombinant tannase (named TanRd) was as high as 27.3 U/mL. TanRd was purified by chromatography and analysed by SDS-PAGE, showing a molecular weight of 75.1 kDa. The specific activity of TanRd towards tannic acid was 676.4 U/mg. Its highest activity was obtained at 40 degreesC, with more than 70% of the activity observed at 25-60 degreesC. Furthermore, it possessed at least 60% of the activity in a broad pH range of 2.5-6.5. Notably, TanRd was excellently stable at a pH range from 3.0 to 8.0; over 65% of its maximum activity remained after incubation. Besides, the broad substrate specificity of TanRd to esters of gallic acid has attracted wide attention. In view of the above, tannase resources were developed from mangrove-derived yeasts for the first time in this study. This tannase can become a promising material in tannin biodegradation and gallic acid production. |
PubMedSearch : Pan_2020_Mar.Drugs_18_ |
PubMedID: 33143376 |
Gene_locus related to this paper: 9basi-a0a4p8xkj5 |
Gene_locus | 9basi-a0a4p8xkj5 |
Pan J, Wang NN, Yin XJ, Liang XL, Wang ZP (2020)
Characterization of a Robust and pH-Stable Tannase from Mangrove-Derived Yeast Rhodosporidium diobovatum Q95
Mar Drugs
18 :
Pan J, Wang NN, Yin XJ, Liang XL, Wang ZP (2020)
Mar Drugs
18 :